Use of inpatient palliative care in metastatic testicular cancer patients undergoing critical care therapy: insights from the national inpatient sample

2025

Inpatient Palliative Care in Metastatic Testicular Cancer Patients

Sample size: 420 publication 10 minutes Evidence: moderate

Author Information

Author(s): Cano Garcia Cristina, Incesu Reha-Baris, Barletta Francesco, Morra Simone, Scheipner Lukas, Baudo Andrea, Tappero Stefano, Piccinelli Mattia Luca, Tian Zhe, Saad Fred, Shariat Shahrokh F., Terrone Carlo, De Cobelli Ottavio, Carmignani Luca, Ahyai Sascha, Longo Nicola, Tilki Derya, Briganti Alberto, Banek Severine, Kluth Luis A., Chun Felix K. H., Karakiewicz Pierre I.

Primary Institution: University of Montréal Health Center

Hypothesis

Rates of inpatient palliative care (IPC) are comparable to those recorded in metastatic lung and breast cancer patients.

Conclusion

The study found that the rates of inpatient palliative care use in metastatic testicular cancer patients receiving critical care therapy increased from 5% to 19% between 2008 and 2019.

Supporting Evidence

Of 420 metastatic testicular cancer patients undergoing critical care therapy, 70 (17%) received inpatient palliative care.
The rates of inpatient palliative care among these patients increased from 5% in 2008 to 19% in 2019.
Patients receiving inpatient palliative care were older and more likely to have do not resuscitate status.

Takeaway

This study looked at how many testicular cancer patients in the hospital got special care to help them feel better while they were very sick, and it found that more patients are getting this care now than before.

Methodology

The study used the Nationwide Inpatient Sample (NIS) database from 2008 to 2019 to analyze IPC rates and predictors in metastatic testicular cancer patients receiving critical care therapy.